Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1423053 MIAMI, FL
Back to MRVI Full portfolio

Position in MRVI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,200,621
+$2,193,896 QoQ
Shares Held
1,484,319
+140.4% QoQ
Ownership
0.575%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MRVI Over Time

Shares Held

Position Value (USD)

Derivatives in MRVI

reported options exposure · as of Mar 31, 2026
CallValue
$215,080
CallShares
76,000
PutValue
$135,557
PutShares
47,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,363,972 across 373 Biotechnology names. MRVI ranks #141 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in MRVI

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $215,080 76,000
2026-03-31 $135,557 47,900
2026-03-31 $4,200,621 1,484,319
2025-12-31 $41,275 12,700
2025-12-31 $2,006,725 617,454
2025-12-31 $489,775 150,700
2025-09-30 $255,010 88,854
2025-09-30 $33,292 11,600
2025-09-30 $449,442 156,600
2025-06-30 $299,563 124,300
2025-06-30 $1,467,058 608,738
2025-06-30 $30,125 12,500
2025-03-31 $97,240 44,000
2025-03-31 $2,362,041 1,068,797
2025-03-31 $28,067 12,700
2024-12-31 $329,725 60,500
2024-12-31 $109,545 20,100
2024-12-31 $114,281 20,969
2024-09-30 $324,921 39,100
2024-09-30 $44,043 5,300
2024-06-30 $2,560,050 357,549
2024-06-30 $15,752 2,200
2024-06-30 $156,088 21,800
2024-03-31 $195,942 22,600
2024-03-31 $2,342,313 270,163
2024-03-31 $128,316 14,800
2023-12-31 $3,275 500
2023-12-31 $1,310 200
2023-12-31 $7,504,216 1,145,682
2023-09-30 $29,000 2,900
2023-09-30 $37,000 3,700
2023-09-30 $17,621,300 1,762,130
2023-06-30 $203,305 16,356
2023-06-30 $63,393 5,100
2023-06-30 $268,488 21,600
2023-03-31 $526,776 37,600
2023-03-31 $50,436 3,600
2023-03-31 $7,293,003 520,557
2022-12-31 $7,101,795 496,282
2022-12-31 $238,977 16,700
2022-12-31 $465,075 32,500
2022-09-30 $505,494 19,800
2022-09-30 $1,455,210 57,000
2022-09-30 $46,570,932 1,824,165
2022-06-30 $3,869,696 136,209
2022-06-30 $838,095 29,500
2022-06-30 $2,684,745 94,500
2022-03-31 $3,999,618 113,400
2022-03-31 $987,560 28,000
2022-03-31 $15,338,605 434,891

Report a Problem

Category
Description
Email (optional, for follow-up)